Geneva Capital Management LLC Catalent, Inc. Transaction History

Geneva Capital Management LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $645,384 - $1.05 Million	14,203 Added 6.33%	238,544 $15.7 Million
Q4 2022 Feb 07, 2023	SELL	$41.39 - $81.0 $1.24 Million - $2.44 Million	-30,063 Reduced 11.82%	224,341 $10.1 Million
Q3 2022 Nov 02, 2022	SELL	$72.36 - $113.1 $993,285 - $1.55 Million	-13,727 Reduced 5.12%	254,404 $18.4 Million
Q2 2022 Aug 02, 2022	SELL	$87.2 - $114.05 $314,879 - $411,834	-3,611 Reduced 1.33%	268,131 $28.8 Million
Q1 2022 May 02, 2022	SELL	$94.19 - $124.49 $1.26 Million - $1.67 Million	-13,395 Reduced 4.7%	271,742 $30.1 Million
Q4 2021 Feb 02, 2022	BUY	$119.57 - $139.07 $6.34 Million - $7.37 Million	53,008 Added 22.84%	285,137 $36.5 Million
Q3 2021 Nov 08, 2021	SELL	$109.17 - $142.35 $1.4 Million - $1.83 Million	-12,869 Reduced 5.25%	232,129 $30.9 Million
Q2 2021 Aug 11, 2021	SELL	$100.34 - $115.69 $1.18 Million - $1.35 Million	-11,712 Reduced 4.56%	244,998 $26.5 Million
Q1 2021 May 03, 2021	BUY	$101.51 - $125.27 $2.7 Million - $3.34 Million	26,625 Added 11.57%	256,710 $27 Million
Q4 2020 Feb 02, 2021	BUY	$85.88 - $105.36 $2.12 Million - $2.61 Million	24,728 Added 12.04%	230,085 $23.9 Million
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $14.9 Million - $19 Million	205,357 New	205,357 $17.6 Million

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Geneva Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Geneva Capital Management LLC with notifications on news.